Evidence map›Paper›PMID 26323090›Full record

ArticlePloS one2015

Integrin Based Isolation Enables Purification of Murine Lineage Committed Cardiomyocytes.

Laura Tarnawski, Xiaojie Xian, Gustavo Monnerat, Iain C Macaulay, Daniela Malan, Andrew Borgman, Sean M Wu, Bernd K Fleischmann, Stefan Jovinge

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Development (Cambridge, England) · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Laura TarnawskiLund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
Xiaojie XianLund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
Gustavo MonneratInstitute of Physiology I, Life and Brain Center, Department of Cardiac Surgery, University of Bonn, Bonn, Germany; Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Iain C MacaulayHaematopoietic Stem Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, England.
Daniela MalanInstitute of Physiology I, Life and Brain Center, Department of Cardiac Surgery, University of Bonn, Bonn, Germany.
Andrew BorgmanSpectrum Health Fredrik Meijer Heart and Vascular Institute, Grand Rapids, Michigan, United States of America.
Sean M WuInstitute for Stem Cell Biology and Regenerative Medicine, Stanford, California, United States of America; Stanford Cardiovascular Institute, Stanford, California, United States of America; Dept of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, California, United States of America.
Bernd K FleischmannInstitute of Physiology I, Life and Brain Center, Department of Cardiac Surgery, University of Bonn, Bonn, Germany; Pharma Center Bonn, University of Bonn, Bonn, Germany.
Stefan JovingeLund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden; Van Andel Research Institute, Grand Rapids, Michigan, United States of America; Spectrum Health Fredrik Meijer Heart and Vascular Institute, Grand Rapids, Michigan, United States of America.
Life & Brain (Germany) · DELund University · SESpectrum Health · USMRC Weatherall Institute of Molecular Medicine · GBStanford University · USUniversity of Bonn · DE

Funding

Enabling Technologies for Human-Machine Hybrid TissuesDP1LM012179 · NLM · STANFORD UNIVERSITY · PI WU, SEAN M · 2014 to 2018
$3.8M
Generation of functional organs via developmental chimerismDP2OD004411 · OD · STANFORD UNIVERSITY · PI WU, SEAN M · 2008 to 2008
$2.5M
Cardiac Progenitor Cells in Development and DiseaseK08HL081086 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WU, SEAN M · 2005 to 2010
$657k
CYTOKINE EFFECTS IN HEMATOPOIETIC CULTUREF32HL009976 · NHLBI · NORTHWESTERN UNIVERSITY · PI WENNING, LARISSA A · 1998 to 1999
–
NHLBI NIH HHS F32 HL009976NHLBI NIH HHS K08 HL081086NHLBI NIH HHS U01 HL009976-05NIH HHS DP2 OD004411NLM NIH HHS DP1 LM012179
6 · The paper itself

Abstract

In contrast to mature cardiomyocytes which have limited regenerative capacity, pluripotent stem cells represent a promising source for the generation of new cardiomyocytes. The tendency of pluripotent stem cells to form teratomas and the heterogeneity from various differentiation stages and cardiomyocyte cell sub-types, however, are major obstacles to overcome before this type of therapy could be applied in a clinical setting. Thus, the identification of extracellular markers for specific cardiomyocyte progenitors and mature subpopulations is of particular importance. The delineation of cardiomyocyte surface marker patterns not only serves as a means to derive homogeneous cell populations by FACS, but is also an essential tool to understand cardiac development. By using single-cell expression profiling in early mouse embryonic hearts, we found that a combination of integrin alpha-1, alpha-5, alpha-6 and N-cadherin enables isolation of lineage committed murine cardiomyocytes. Additionally, we were able to separate trabecular cardiomyocytes from solid ventricular myocardium and atrial murine cells. These cells exhibit expected subtype specific phenotype confirmed by electrophysiological analysis. We show that integrin expression can be used for the isolation of living, functional and lineage-specific murine cardiomyocytes.

Indexed as

AnimalsBiomarkersCadherinsCell DifferentiationCell LineGene Expression ProfilingIntegrinsMaleMiceMice, Inbred C57BLMice, TransgenicMyocardiumMyocytes, CardiacPluripotent Stem CellsBiomarkersCadherinsIntegrins

Identifiers

PMID26323090
PMCPMC4556377
OpenAlexW2147670493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.